KCT0008395RecruitingUnknown
Evaluation of the safety and usefulness of 5-FU local injection for the treatment of advanced gastric cancer
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Enrollment
- 35
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •Patients aged 18 years or older with histologically confirmed adenocarcinoma and diagnosed with advanced gastric cancer that is not amenable to radical resection at the time of diagnosis who meet the following conditions are eligible.
- •Patients who have failed standard treatment or for whom standard treatment is not feasible,
- •Patients with measurable lesions in the stomach on endoscopy,
- •Patients with a predicted survival time of 3 months or more.
Exclusion Criteria
- •?Patients with a history of cancer other than gastric cancer
- •?Patients who do not consent to this treatment
- •?Nursing mothers other than pregnant women or women of childbearing potential who are planning to become pregnant
- •?Patients receiving Tegapur-Gimeracil-Oterasil potassium combination and patients who have stopped taking it within 7 days.
- •?Patients receiving sorbudine
- •?Patients with a history of severe hypersensitivity to 5-FU
- •?Patients with bone marrow depression after treatment with other antineoplastic agents, radiation therapy, or extreme frailty
- •?Patients with non-malignant tumor disease
Investigators
Similar Trials
Completed
Phase 2
Assessment of the efficacy and safety of 5-FU/CDDP/Cetuximab (FPE) induction chemotherapy in patients with locally advanced head and neck squamous cell carcinomalocally advanced head and neck squamous cell carcinomaJPRN-UMIN000031146Saga University25
Completed
Phase 2
Evaluation of safety and protective efficacy of fulminant hepatitis to abatacept treatment of patients with HBV-related severe hepatitis.-Pilot StudyHBV-related acute severe hepatitisJPRN-UMIN000025725Hiroshima university hospital10
Active, not recruiting
Not Applicable
A Randomised Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Proapectively the Prognostic Value of Molecular MarkersEUCTR2007-001195-36-IEAll Ireland Cooperative Oncology Research Group (ICORG)3,610
Recruiting
Phase 2
Effectiveness of 5% fluorouracil ointment in the treatment of genital wartsGenital wart.Viral wartsIRCT20230913059421N1Ahvaz University of Medical Sciences60
Recruiting
Phase 2
Evaluation of Firooz fissure cream containing lanolin in improving the pain and severity of fissure lesionsFissure of nipple.Fissure and fistula of nippleN64.0IRCT20190210042676N27Firooz Health Group Company20